IBRX - Company ID 0001326110
As of 2026-11-06, ImmunityBio, Inc. (IBRX) has a market capitalization of $8.73 B, making it the #1004 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $8.73 B |
| 2026-11-05 | $8.39 B |
| 2026-11-04 | $9.35 B |
| 2026-11-03 | $8.68 B |
| 2026-11-02 | $8.39 B |
| 2026-11-01 | $8.68 B |
| 2026-10-31 | $8.68 B |
| 2026-10-30 | $8.65 B |
| 2026-10-29 | $9.12 B |
| 2026-10-28 | $9.23 B |
| 2026-10-27 | $9.04 B |
| 2026-10-26 | $8.18 B |
As of 2026-11-06, ImmunityBio, Inc. (IBRX) has a market capitalization of $8.73 B, making it the #1004 most valuable US-listed company.
ImmunityBio, Inc. is the #1004 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $8.61 B |
| 2026-10-24 | $8.61 B |
| 2026-10-23 | $8.62 B |
| 2026-10-22 | $8.70 B |
| 2026-10-21 | $9.13 B |
| 2026-10-20 | $9.23 B |
| 2026-10-19 | $8.82 B |
| 2026-10-18 | $9.61 B |
| 2026-10-17 | $9.61 B |
| 2026-10-16 | $9.61 B |
| 2026-10-15 | $10.47 B |
| 2026-10-14 | $10.38 B |
| 2026-10-13 | $10.52 B |
| 2026-10-12 | $10.57 B |
| 2026-10-11 | $11.01 B |
| 2026-10-10 | $11.01 B |
| 2026-10-09 | $11.01 B |
| 2026-10-08 | $10.36 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.